ReviewJournal of cardiothoracic surgery2025

Knowledge domain and emerging trends on the SGLT2 inhibitor dapagliflozin for heart failure: a bibliometric analysis from 2012 to 2024.

Mengxuan Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.